Akums Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
- Paid Up Capital ₹ 31.48 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 305.23 Cr
- Satisfied Charges ₹ 468.16 Cr
About Akums Drugs And Pharmaceuticals
Akums Drugs And Pharmaceuticals Limited (ADAPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 19 April 2004 and has a history of 20 years and ten months. Its registered office is in North West Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 31.48 Cr.
The company currently has active open charges totaling ₹305.23 Cr. The company has closed loans amounting to ₹468.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Akums Drugs And Pharmaceuticals Limited India are Sumeet Sood as CFO and Dharamvir Malik as Company Secretary. Kewal Handa, Satwinder Singh, Sanjeev Jain, and Five other members serve as directors at the Company.
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239DL2004PLC125888
- Company No.
125888
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2004
- Date of AGM
31 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Akums Drugs And Pharmaceuticals Limited offer?
Akums Drugs And Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pharmaceutical Capsules, Softgel Capsules, Eye Care Medicines, Eye Drops, Ear Drops, Allopathic Ear Drop, Ayurvedic Joint Pain Relief Medicine, Herbal Joint Pain Relief Tablets.
Who are the key members and board of directors at Akums Drugs And Pharmaceuticals?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumeet Sood  | CFO | Current | |
| Dharamvir Malik | Company Secretary | Current | |
| Sanjeev Jain | Managing Director | 19-Apr-2004 | Current |
| Sandeep Jain | Managing Director | 19-Apr-2004 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satwinder Singh | Director | Current | |
| Matangi Gowrishankar | Director | 16-Mar-2022 | Current |
| Kewal Handa | Director | 16-Mar-2022 | Current |
| Sunil Thakur | Nominee Director | Current | |
| Sanjay Sinha | Whole-Time Director | Current | |
| Nand Kalra | Director | 01-Jun-2012 | Current |
Financial Performance of Akums Drugs And Pharmaceuticals.
Akums Drugs And Pharmaceuticals Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Akums Drugs And Pharmaceuticals?
In 2024, Akums Drugs And Pharmaceuticals had a promoter holding of 84.87% and a public holding of 15.13%. The company had 14 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wellness Forever Medicare LimitedKewal Handa is a mutual person
Salus Lifecare Private LimitedKewal Handa is a mutual person
Omsav Pharma Research Private LimitedKewal Handa is a mutual person
Infiiloom India Private LimitedKewal Handa is a mutual person
Gujarat Pipavav Port LimitedMatangi Gowrishankar is a mutual person
Poonawalla Fincorp LimitedKewal Handa is a mutual person
Charges (Loans)
₹305.23 Cr
₹468.16 Cr
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 305.00 Cr
- Others : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2023 | Sbicap Trustee Company Limited | ₹305.00 Cr | Open |
| 03 Feb 2020 | Others | ₹2.25 M | Open |
| 15 Jul 2022 | Yes Bank Limited | ₹60.00 Cr | Satisfied |
| 13 Jul 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹50.00 Cr | Satisfied |
| 11 Apr 2022 | Citi Bank N.A. | ₹25.00 Cr | Satisfied |
How Many Employees Work at Akums Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Akums Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akums Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akums Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
